Cargando…

Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II

Cardiac hypertrophy is an important risk factor for heart failure. Epidermal growth factor receptor (EGFR) has been found to play a role in the pathogenesis of various cardiovascular diseases. The aim of this current study was to examine the role of EGFR in angiotensin II (Ang II)‐induced cardiac hy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Kesong, Tian, Xinqiao, Qian, Yuanyuan, Skibba, Melissa, Zou, Chunpeng, Liu, Zhiguo, Wang, Jingying, Xu, Zheng, Li, Xiaokun, Liang, Guang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759478/ https://www.ncbi.nlm.nih.gov/pubmed/26762600 http://dx.doi.org/10.1111/jcmm.12763

Ejemplares similares

EGFR inhibition attenuates diabetic nephropathy through decreasing ROS and endoplasmic reticulum stress
por: Xu, Zheng, et al.
Publicado: (2017)

CD38 promotes angiotensin II‐induced cardiac hypertrophy
por: Guan, Xiao‐Hui, et al.
Publicado: (2017)

Anti-Interleukin-22-Neutralizing Antibody Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Mice
por: Ye, Jing, et al.
Publicado: (2017)

Erratum to “Anti-Interleukin-22-Neutralizing Antibody Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Mice”
por: Ye, Jing, et al.
Publicado: (2018)

Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy
por: Bhullar, Sukhwinder K., et al.
Publicado: (2022)

11β-HSD1 inhibition ameliorates diabetes-induced cardiomyocyte hypertrophy and cardiac fibrosis through modulation of EGFR activity
por: Zou, Chunpeng, et al.
Publicado: (2017)

Effect of endostatin overexpression on angiotensin II-induced cardiac hypertrophy in rats
por: Dai, You-Jin, et al.
Publicado: (2019)

Paeonol improves angiotensin II-induced cardiac hypertrophy by suppressing ferroptosis
por: Liu, Canzhang, et al.
Publicado: (2023)

Rutaecarpine Ameliorates Pressure Overload Cardiac Hypertrophy by Suppression of Calcineurin and Angiotensin II
por: Li, Shujun, et al.
Publicado: (2021)

Angiotensin II induces kidney inflammatory injury and fibrosis through binding to myeloid differentiation protein-2 (MD2)
por: Xu, Zheng, et al.
Publicado: (2017)

Dapagliflozin Mediates Plin5/PPARα Signaling Axis to Attenuate Cardiac Hypertrophy
por: Yu, Jing, et al.
Publicado: (2021)

Author Correction: Angiotensin II induces kidney inflammatory injury and fibrosis through binding to myeloid differentiation protein-2 (MD2)
por: Xu, Zheng, et al.
Publicado: (2021)

DIOL Triterpenes Block Profibrotic Effects of Angiotensin II and Protect from Cardiac Hypertrophy
por: Martín, Ruben, et al.
Publicado: (2012)

Upregulation of M(3) muscarinic receptor inhibits cardiac hypertrophy induced by angiotensin II
por: Liu, Yan, et al.
Publicado: (2013)

Angiotensin II-induced cardiac hypertrophy and fibrosis are promoted in mice lacking Fgf16
por: Matsumoto, Emi, et al.
Publicado: (2013)

Effect of the Shensong Yangxin Capsule on Energy Metabolism in Angiotensin II-Induced Cardiac Hypertrophy
por: Liu, Bei-Lei, et al.
Publicado: (2018)

Transmembrane protein 117 knockdown protects against angiotensin-II-induced cardiac hypertrophy
por: Yang, Yi, et al.
Publicado: (2023)

A Newly Designed Curcumin Analog Y20 Mitigates Cardiac Injury via Anti-Inflammatory and Anti-Oxidant Actions in Obese Rats
por: Qian, Yuanyuan, et al.
Publicado: (2015)

Angiotensin-Converting Enzyme 2 Over-Expression in the Central Nervous System Reduces Angiotensin-II-Mediated Cardiac Hypertrophy
por: Feng, Yumei, et al.
Publicado: (2012)

Lercanidipine attenuates angiotensin II-induced cardiomyocyte hypertrophy by blocking calcineurin-NFAT3 and CaMKII-HDAC4 signaling
por: Chen, Yuezhang, et al.
Publicado: (2017)

Metformin attenuates angiotensin II-induced cardiomyocyte hypertrophy by upregulating the MuRF1 and MAFbx pathway
por: Du, Fawang, et al.
Publicado: (2021)

Angiotensin II Receptor Blockers and Arrhythmias in Ventricular Hypertrophy
por: Salama, Guy
Publicado: (2022)

Placental extract suppresses cardiac hypertrophy and fibrosis in an angiotensin II-induced cachexia model in mice
por: Yamauchi, Akihiro, et al.
Publicado: (2019)

Melatonin alleviates angiotensin-II-induced cardiac hypertrophy via activating MICU1 pathway
por: Yang, Yi, et al.
Publicado: (2020)

Angiotensin II type 1 receptor blockade attenuates gefitinib-induced cardiac hypertrophy via adjusting angiotensin II-mediated oxidative stress and JNK/P38 MAPK pathway in a rat model
por: Alanazi, Wael A., et al.
Publicado: (2022)

I-κB Kinase-ε Deficiency Attenuates the Development of Angiotensin II-Induced Myocardial Hypertrophy in Mice
por: Cao, Yide, et al.
Publicado: (2021)

Effect of SKF-96365 on cardiomyocyte hypertrophy induced by angiotensin II
por: Cheng, Huijun, et al.
Publicado: (2020)

Herpud1 suppress angiotensin II induced hypertrophy in cardiomyocytes
por: Mikawa, Mei, et al.
Publicado: (2022)

EGFR mediates hyperlipidemia-induced renal injury via regulating inflammation and oxidative stress: the detrimental role and mechanism of EGFR activation
por: Fang, Qilu, et al.
Publicado: (2016)

Mice lacking the Cβ subunit of PKA are resistant to angiotensin II-induced cardiac hypertrophy and dysfunction
por: Enns, Linda C, et al.
Publicado: (2010)

Concerted Regulation of cGMP and cAMP Phosphodiesterases in Early Cardiac Hypertrophy Induced by Angiotensin II
por: Mokni, Walid, et al.
Publicado: (2010)

Sex differences in the response to angiotensin II receptor blockade in a rat model of eccentric cardiac hypertrophy
por: Walsh-Wilkinson, Élisabeth, et al.
Publicado: (2019)

Overexpression of peptidase inhibitor 16 attenuates angiotensin II–induced cardiac fibrosis via regulating HDAC1 of cardiac fibroblasts
por: Deng, Mengqing, et al.
Publicado: (2020)

The orphan receptor TR3 participates in angiotensin II-induced cardiac hypertrophy by controlling mTOR signalling
por: Wang, Rong-Hao, et al.
Publicado: (2013)

β-catenin/LEF1/IGF-IIR Signaling Axis Galvanizes the Angiotensin-II- induced Cardiac Hypertrophy
por: Lai, Chin-Hu, et al.
Publicado: (2019)

Stretch-Induced Biased Signaling in Angiotensin II Type 1 and Apelin Receptors for the Mediation of Cardiac Contractility and Hypertrophy
por: Seo, Kinya, et al.
Publicado: (2020)

Role of PI3-Kinase in Angiotensin II-Induced Cardiac Hypertrophy: Class I Versus Class III
por: Zhong, Tiecheng, et al.
Publicado: (2021)

MiR-410-3p facilitates Angiotensin II–induced cardiac hypertrophy by targeting Smad7
por: Jia, Guizhi, et al.
Publicado: (2021)

Effect of hepatocyte growth factor and angiotensin II on rat cardiomyocyte hypertrophy
por: Chen, Ai-Lan, et al.
Publicado: (2012)

Hydroxysafflor yellow A protects against angiotensin II-induced hypertrophy
por: Ni, Bin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ctf8nbmqsvf27tt9rivkb61udt